These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26005408)

  • 21. Site-directed mutagenesis of the human beta3-adrenoceptor--transmembrane residues involved in ligand binding and signal transduction.
    Gros J; Manning BS; Pietri-Rouxel F; Guillaume JL; Drumare MF; Strosberg AD
    Eur J Biochem; 1998 Feb; 251(3):590-6. PubMed ID: 9490030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells.
    Crider JY; Williams GW; Drace CD; Katoli P; Senchyna M; Sharif NA
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4837-44. PubMed ID: 14578406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of mutations at conserved TM II residues on ligand binding and activation of mouse 5-HT6 receptor.
    Zhang J; Shen CP; Xiao JC; Lanza TJ; Lin LS; Francis BE; Fong TM; Chen RZ
    Eur J Pharmacol; 2006 Mar; 534(1-3):77-82. PubMed ID: 16612839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular determinants of ligand binding at the human histamine H
    Cordova-Sintjago TC; Fang L; Bruysters M; Leurs R; Booth RG
    J Chem Pharm Res; 2012 Jun; 4(6):2937-2951. PubMed ID: 25013351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms.
    Lovenberg TW; Baron BM; de Lecea L; Miller JD; Prosser RA; Rea MA; Foye PE; Racke M; Slone AL; Siegel BW
    Neuron; 1993 Sep; 11(3):449-58. PubMed ID: 8398139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor.
    Jiang Q; Guo D; Lee BX; Van Rhee AM; Kim YC; Nicholas RA; Schachter JB; Harden TK; Jacobson KA
    Mol Pharmacol; 1997 Sep; 52(3):499-507. PubMed ID: 9281613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties.
    Rauly-Lestienne I; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Cussac D
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Oct; 376(1-2):93-105. PubMed ID: 17786406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of a 5-HT7 receptor positively coupled to adenylate cyclase activation in human granulosa-lutein cells.
    Graveleau C; Paust HJ; Schmidt-Grimminger D; Mukhopadhyay AK
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1277-86. PubMed ID: 10720076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
    Nachtergael I; Gaspard N; Langlet C; Robberecht P; Langer I
    Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
    Adham N; Zgombick JM; Bard J; Branchek TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
    Haskell-Luevano C; Cone RD; Monck EK; Wan YP
    Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional importance of the carboxyl tail cysteine residues in the human D1 dopamine receptor.
    Jensen AA; Pedersen UB; Kiemer A; Din N; Andersen PH
    J Neurochem; 1995 Sep; 65(3):1325-31. PubMed ID: 7643110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites.
    Moro S; Guo D; Camaioni E; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 1998 Apr; 41(9):1456-66. PubMed ID: 9554879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors.
    Andressen KW; Manfra O; Brevik CH; Ulsund AH; Vanhoenacker P; Levy FO; Krobert KA
    Br J Pharmacol; 2015 Aug; 172(15):3846-60. PubMed ID: 25884989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b).
    Jasper JR; Kosaka A; To ZP; Chang DJ; Eglen RM
    Br J Pharmacol; 1997 Sep; 122(1):126-32. PubMed ID: 9298538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered adenylyl cyclase responsiveness subsequent to point mutations of Asp 128 in the third transmembrane domain of the delta-opioid receptor.
    Cavalli A; Babey AM; Loh HH
    Neuroscience; 1999; 93(3):1025-31. PubMed ID: 10473267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5.
    Shapiro DA; Kristiansen K; Kroeze WK; Roth BL
    Mol Pharmacol; 2000 Nov; 58(5):877-86. PubMed ID: 11040033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric Inhibition of Serotonin 5-HT
    Satała G; Duszyńska B; Lenda T; Nowak G; Bojarski AJ
    Mol Neurobiol; 2018 Apr; 55(4):2897-2910. PubMed ID: 28455702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors.
    Bonsi P; Cuomo D; Ding J; Sciamanna G; Ulrich S; Tscherter A; Bernardi G; Surmeier DJ; Pisani A
    Neuropsychopharmacology; 2007 Aug; 32(8):1840-54. PubMed ID: 17203014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stable expression of adenylyl cyclase 2 leads to the functional rescue of human 5-HT6 receptor in a CHODUKX cell line.
    Nawoschik SP; Olsen M; Smith DL; Khawaja X
    J Pharmacol Toxicol Methods; 2007; 55(3):323-31. PubMed ID: 17188522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.